Discounted Cash Flow Rating

Sell

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Neutral

Analyst Rating

Sell

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Buy

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

Esperion Therapeutics, Inc. (ESPR)

Pharmaceutical Preparations

https://www.esperion.com

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment.

3891 RANCHERO DRIVE, SUITE 150
ANN ARBOR, MI

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

06/26/2013

Market Cap

372,288,900

Shares Outstanding

113,720,000

Weighted SO

113,717,785

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

ELAN --.--%

SIGA --.--%

INVVY --.--%

CTLT --.--%

EGRX --.--%

ANIP --.--%

PAHC --.--%

DCPH --.--%

PBH --.--%

Beta

1.0210

Last Div

0.0000

Range

0.7-3.4

Chg

-0.0050

Avg Vol

7381264

Mkt Cap

372288900

Exch

NASDAQ

Country

US

Phone

734 887 3903

DCF Diff

2.5173

DCF

-0.0222

Div Yield

0.0000

P/S

1.3402

EV Multiple

148.9966

P/FV

-1.0777

Div Yield %

0.0000

P/E

-3.7664

PEG

-0.3945

Payout

0.0000

Current Ratio

1.9682

Quick Ratio

1.4865

Cash Ratio

1.0797

DSO

79.3101

DIO

610.1681

Op Cycle

689.4782

DPO

344.3406

CCC

345.1377

Gross Margin

0.8181

Op Margin

0.0178

Pretax Margin

-0.3546

Net Margin

-0.3546

Eff Tax Rate

0.2791

ROA

-0.2796

ROE

0.2620

ROCE

0.0280

NI/EBT

1.0000

EBT/EBIT

-19.9064

EBIT/Rev

0.0178

Debt Ratio

1.5686

D/E

-1.6055

LT Debt/Cap

2.9897

Total Debt/Cap

2.6515

Int Coverage

-0.1787

CF/Debt

-0.0494

Equity Multi

-1.0235

Rec Turnover

4.6022

Pay Turnover

1.0600

Inv Turnover

0.5982

FA Turnover

38.8243

Asset Turnover

0.7885

OCF/Share

-0.1446

FCF/Share

-0.1450

Cash/Share

1.0027

OCF/Sales

-0.0983

FCF/OCF

1.0027

CF Coverage

-0.0494

ST Coverage

-0.7706

CapEx Coverage

-374.0137

Div&CapEx Cov

-374.0137

P/BV

-1.0777

P/B

-1.0777

P/S

1.3402

P/E

-3.7664

P/FCF

-13.5991

P/OCF

-13.5875

P/CF

-13.5875

PEG

-0.3945

P/S

1.3402

EV Multiple

148.9966

P/FV

-1.0777

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Jan 18, 21:15 Esperion Announces Pricing of $85.1 Million Public Offering of Common Stock GlobeNewswire Inc. Jan 18, 21:15 Esperion Announces Pricing of $85.1 Million Public Offering of Common Stock GlobeNewswire Inc. Jan 18, 21:15 Esperion Announces Pricing of $85.1 Million Public Offering of Common Stock GlobeNewswire Inc. Jan 18, 21:15 Esperion Announces Pricing of $85.1 Million Public Offering of Common Stock GlobeNewswire Inc. Jan 18, 21:15 Esperion Announces Pricing of $85.1 Million Public Offering of Common Stock MarketWatch Jan 18, 12:23 If this is all the downside bears can pack, then the bull market may have room MarketWatch Jan 13, 08:03 Beware the ‘January defect.’ Stocks are now in a bearish stretch. MarketWatch Jan 12, 13:46 Beware the ‘January defect.’ Stocks are now in a bearish stretch. MarketWatch Jan 12, 13:46 Beware the ‘January defect.’ Stocks are now in a bearish stretch. MarketWatch Jan 11, 18:09 Beware the ‘January defect.’ Stocks are now in a bearish stretch. MarketWatch Jan 11, 16:26 Beware the ‘January defect.’ Stocks are now in a bearish stretch. MarketWatch Jan 06, 06:05 Santa didn’t come to Wall Street and stocks now face rough sledding MarketWatch Jan 04, 13:32 Santa didn’t come to Wall Street and stocks now face rough sledding MarketWatch Dec 30, 04:56 'All systems go' for investors as stocks power 2023's gains into 2024 MarketWatch Dec 30, 04:53 'All systems go' for investors as stocks power 2023's gains into 2024 Benzinga Dec 29, 10:45 Global Mofy Metaverse Reports Follow-on Offering, Joins Lyft, Coinbase Global And Other Big Stocks Moving Lower On Friday MarketWatch Dec 29, 05:44 'All systems go' for investors as stocks power 2023's gains into 2024 MarketWatch Dec 28, 16:09 'All systems go' for investors as stocks power 2023's gains into 2024 MarketWatch Dec 28, 16:09 'All systems go' for investors as stocks power 2023's gains into 2024 Benzinga Nov 13, 13:00 Analyst Expectations for Esperion Therapeutics's Future

Revenue Product Segmentation